Andrey Semenov

1.2k total citations
6 papers, 16 citations indexed

About

Andrey Semenov is a scholar working on Oncology, Surgery and Computer Networks and Communications. According to data from OpenAlex, Andrey Semenov has authored 6 papers receiving a total of 16 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Surgery and 1 paper in Computer Networks and Communications. Recurrent topics in Andrey Semenov's work include Cancer Immunotherapy and Biomarkers (3 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Andrey Semenov is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Bladder and Urothelial Cancer Treatments (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Andrey Semenov collaborates with scholars based in Russia, Türkiye and South Korea. Andrey Semenov's co-authors include Craig Gedye, Rustem Gafanov, Jae‐Lyun Lee, Erhan Gökmen, Fatih Köse, Mihaela Munteanu, Rodolfo F. Perini, Alejandro Acevedo, Primo N. Lara and Mustafa Erman and has published in prestigious journals such as Journal of Clinical Oncology, European Urology and BMC Cancer.

In The Last Decade

Andrey Semenov

5 papers receiving 15 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrey Semenov Russia 2 7 6 5 3 3 6 16
Rose Edmonds United States 3 9 1.3× 3 0.5× 4 0.8× 2 0.7× 5 1.7× 6 24
Esha Banerjee United States 2 10 1.4× 4 0.7× 5 1.0× 3 1.0× 3 21
Alejandro Acevedo South Korea 3 6 0.9× 5 0.8× 4 0.8× 3 1.0× 3 1.0× 5 18
Nancy Roche United States 2 9 1.3× 3 0.5× 5 1.0× 2 0.7× 5 21
Anastasia Shcherban Finland 2 6 0.9× 5 0.8× 5 1.0× 2 0.7× 2 11
Koichi Azuma Japan 3 7 1.0× 6 1.0× 5 1.0× 2 0.7× 5 12
David Nicol Australia 2 7 1.0× 4 0.7× 3 0.6× 3 1.0× 2 13
Changquan Ling China 3 12 1.7× 4 0.7× 4 0.8× 3 1.0× 3 17
Heba Gamal Egypt 2 3 0.4× 4 0.7× 4 0.8× 2 0.7× 3 16
Robin De Putter Belgium 4 7 1.0× 5 0.8× 4 0.8× 1 0.3× 6 33

Countries citing papers authored by Andrey Semenov

Since Specialization
Citations

This map shows the geographic impact of Andrey Semenov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey Semenov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey Semenov more than expected).

Fields of papers citing papers by Andrey Semenov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey Semenov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey Semenov. The network helps show where Andrey Semenov may publish in the future.

Co-authorship network of co-authors of Andrey Semenov

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey Semenov. A scholar is included among the top collaborators of Andrey Semenov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey Semenov. Andrey Semenov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Koshkin, Vadim S., Pongwut Danchaivijitr, Woo Kyun Bae, et al.. (2024). Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy. European Urology. 87(4). 390–395. 1 indexed citations
2.
Lara, Primo N., Luis J. Villanueva-Rivera, Carolina Ibáñez, et al.. (2024). A randomized, open-label, phase 3 trial of pembrolizumab plus epacadostat versus sunitinib or pazopanib as first-line treatment for metastatic renal cell carcinoma (KEYNOTE-679/ECHO-302). BMC Cancer. 23(S1). 1253–1253. 11 indexed citations
3.
Özyılkan, Özgür, Ray McDermott, Andrey Semenov, et al.. (2023). Outcomes by complete response to first-line pembrolizumab or platinum-based chemotherapy in advanced urothelial carcinoma (UC) in KEYNOTE-361.. Journal of Clinical Oncology. 41(16_suppl). 4513–4513. 1 indexed citations
4.
5.
Semenov, Andrey. (2014). The Theory of Physical Culture and Sport. Actual directions of scientific researches of the XXI century theory and practice. 1(1). 242–247.
6.
Sherstnev, A., V. Bunichev, M. Dubinin, et al.. (2009). CompHEP status report (version 4.5). Proceedings Of Science. 8–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026